Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALD
3826
DELISTED
Callidus Software, Inc.
CALD
| $1.26M | ﹤0.01% |
75,303
+19,393
| +35% | +$287K |
|
3827
Alaunos Therapeutics
TCRT
$4.64M
| $1.25M | ﹤0.01% |
1,128
-450
| -29% | -$461K |
|
|
CSW
3828
CSW Industrials
CSW
$5.69B
| $1.25M | ﹤0.01% |
39,756
+23,804
| +149% | +$764K |
|
3829
HealthEquity
HQY
$8.78B
| $1.25M | ﹤0.01% |
50,637
-34,992
| -41% | -$750K |
|
3830
Ares Management
ARES
$32.2B
| $1.25M | ﹤0.01% |
81,011
+20,651
| +34% | +$254K |
|
|
JSC
3831
DELISTED
SPDR SER TR SPDR RUSSELL/NOMURA SM CAP JAPAN ETF
JSC
| $1.25M | ﹤0.01% |
23,506
+500
| +2% | +$25.4K |
|
|
ABCO
3832
DELISTED
Advisory Board Co
ABCO
| $1.25M | ﹤0.01% |
38,679
-331,770
| -90% | -$12.4M |
|
3833
CorVel
CRVL
$3.01B
| $1.25M | ﹤0.01% |
94,827
+45,147
| +91% | +$635K |
|
3834
PUT
KLA
KLAC
$255B
| $1.25M | ﹤0.01% |
171,000
-350,000
| -67% | -$2.35M |
|
3835
NatWest
NWG
$76.1B
| $1.25M | ﹤0.01% |
181,181
-110,582
| -38% | -$839K |
|
|
HCR
3836
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $1.25M | ﹤0.01% |
251,092
-482,171
| -66% | -$2.38M |
|
|
FPO
3837
DELISTED
First Potomac Realty Trust
FPO
| $1.24M | ﹤0.01% |
137,289
-50,598
| -27% | -$466K |
|
3838
Zevra Therapeutics
ZVRA
$622M
| $1.24M | ﹤0.01% |
5,360
+1,453
| +37% | +$352K |
|
3839
Primoris Services
PRIM
$4.93B
| $1.24M | ﹤0.01% |
51,106
+36,711
| +255% | +$783K |
|
3840
CALL
Zions Bancorporation
ZION
$10.5B
| $1.24M | ﹤0.01% |
51,300
-14,000
| -21% | -$322K |
|
|
RATE
3841
DELISTED
Bankrate Inc
RATE
| $1.24M | ﹤0.01% |
135,470
+121,501
| +870% | +$1.27M |
|
|
VA
3842
DELISTED
Virgin America Inc.
VA
| $1.24M | ﹤0.01% |
32,145
+18,070
| +128% | +$562K |
|
3843
Martin Midstream Partners
MMLP
$95.5M
| $1.24M | ﹤0.01% |
61,653
-113,412
| -65% | -$1.96M |
|
3844
PUT
Post Holdings
POST
$4.11B
| $1.24M | ﹤0.01% |
+27,504
| New | +$1.16M |
|
|
VEDL
3845
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $1.24M | ﹤0.01% |
224,962
-5,417
| -2% | -$25.2K |
|
3846
iShares Morningstar Small-Cap ETF
ISCB
$292M
| $1.24M | ﹤0.01% |
37,112
| – | – |
|
|
CA
3847
CALL
DELISTED
CA, Inc.
CA
| $1.24M | ﹤0.01% |
40,100
-70,000
| -64% | -$2.01M |
|
|
GOLD
3848
CALL
DELISTED
Randgold Resources Ltd
GOLD
| $1.24M | ﹤0.01% |
13,600
-9,452
| -41% | -$759K |
|
3849
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.52B
| $1.23M | ﹤0.01% |
37,100
-3,500
| -9% | -$112K |
|
3850
Korea Electric Power
KEP
$15.8B
| $1.23M | ﹤0.01% |
47,877
+27,368
| +133% | +$625K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.